E2F1 Reduces Sorafenib’s Sensitivity of Esophageal Carcinoma Cells viaModulating the miR-29c-3p/COL11A1 Signaling Axis

E2F1 affected the viability, cell cycle, and apoptosis of ESCA cells by modulating miR-29c-3p/COL11A1, and it attenuated the sensitivity of ESCA cells to sorafenib, shedding new light on the treatment of ESCA.